Evidence map›Paper›PMID 28822002›Full record

ArticleAIDS and behavior2017

Food Insecurity, HIV Disease Progression and Access to Care Among HIV-Infected Russians not on ART.

Bulat Idrisov, Karsten Lunze, Debbie M Cheng, Elena Blokhina, Natalia Gnatienko, Gregory J Patts, Carly Bridden, Ronald E Kleinman, Sheri D Weiser, Evgeny Krupitsky and 1 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Bulat IdrisovClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine/Boston Medical Center, 801 Massachusetts Ave., 2nd Floor, Boston, MA, 02118, USA.
Karsten LunzeClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine/Boston Medical Center, 801 Massachusetts Ave., 2nd Floor, Boston, MA, 02118, USA.
Debbie M ChengDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Elena BlokhinaLaboratory of Clinical Pharmacology of Addictions, First Pavlov State Medical University, St. Petersburg, Russia.
Natalia GnatienkoClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Gregory J PattsData Coordinating Center, Boston University School of Public Health, Boston, MA, USA.
Carly BriddenClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Ronald E KleinmanDepartment of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.
Sheri D WeiserDivision of HIV, Infectious Disease and Global Medicine, Department of Medicine, UCSF, San Francisco, USA.
Evgeny KrupitskyLaboratory of Clinical Pharmacology of Addictions, First Pavlov State Medical University, St. Petersburg, Russia.
Jeffrey H SametClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine/Boston Medical Center, 801 Massachusetts Ave., 2nd Floor, Boston, MA, 02118, USA. jsamet@bu.edu.
Boston University · USBoston Medical Center · USFirst Pavlov State Medical University of St. Petersburg · RUMassachusetts General Hospital · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Clinical Addiction Research and Education ProgramR25DA013582 · NIDA · BOSTON MEDICAL CENTER · PI JEFFREY H. SAMET, Alexander Yale Walley · 2001 to 2026
$8.9M
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected RussiansU01AA020780 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2011 to 2021
$4.4M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & OutcomesR01DA032082 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2015
$3.4M
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH CohortU01AA021989 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2012 to 2016
$3.3M
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsR00DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2018 to 2020
$906k
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject DrugsK99DA041245 · NIDA · BOSTON MEDICAL CENTER · PI LUNZE, KARSTEN · 2016 to 2017
$355k
NIAAA NIH HHS U01 AA020780NIAAA NIH HHS U01AA020780NIAAA NIH HHS U01 AA021989NIAAA NIH HHS U01AA021989NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24AA020778NIAAA NIH HHS U24 AA020779NIAAA NIH HHS U24AA020779NIAID NIH HHS P30 AI042853NIDA NIH HHS INVEST Drug Abuse Research FellowshipNIDA NIH HHS K99 DA041245NIDA NIH HHS K99DA041245NIDA NIH HHS R00 DA041245NIDA NIH HHS R01DA032082NIDA NIH HHS R25 DA013582
6 · The paper itself

Abstract

Food insecurity (FI) has been associated with HIV disease progression among people on antiretroviral therapy (ART), presumably a consequence of poor medication adherence. We assessed whether there is a longitudinal association between FI and two primary outcomes reflecting on HIV disease progression (i.e., CD4 count and time to ART initiation) among people not on ART. Analyses used linear mixed effects and Cox models controlling for confounders. In this cohort (n = 310) FI was common (53%). Most (71.3%) reported past month heavy alcohol use and 37.1% reported past month injection drug use. Only 50 participants initiated ART during the study and mean time to ART was 128 days (SD 120). There were no significant differences in CD4 cell count between the groups with mild/moderate FI or severe FI versus those with no FI [adjusted mean difference, mild/moderate insecurity versus no FI -32.5 (95% CI -94.3, 29.3); severe versus no FI -45.5 (95% CI -124.1, 33.0); global p = 0.42]. We found no significant association between FI and longer time to ART initiation (p = 0.36). Food security is a desirable goal for overall health and shown beneficial for those on ART, however it does not appear to be associated with HIV disease progression among those with high prevalence of substance use and not yet on ART.

Indexed as

Disease ProgressionFood SupplyAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCohort StudiesFemaleHealth Services AccessibilityHIV InfectionsHumansLongitudinal StudiesMaleMedication AdherenceMiddle AgedRussiaSubstance-Related DisordersAnti-Retroviral AgentsAccess to careFood insecurityHIV progressionRussia

Identifiers

PMID28822002
PMCPMC5705384
OpenAlexW2747843985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.